The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Patients
2.2. Hemodynamic Studies—Right Heart Catheterization
2.3. Balloon Pulmonary Angioplasty
2.4. Assessment of Complications and Follow-Up
2.5. Statistical Analysis
3. Results
3.1. Baseline Characteristics
3.2. BPA Procedures and Outcomes
3.3. Complications
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Lang, I.M.; Dorfmüller, P.; Noordegraaf, A.V. The Pathobiology of Chronic Thromboembolic Pulmonary Hypertension. Ann. Am. Thorac. Soc. 2016, 13 (Suppl. S3), S215–S221. [Google Scholar] [CrossRef] [PubMed]
- Humbert, M.; Kovacs, G.; Hoeper, M.M.; Badagliacca, R.; Berger, R.M.F.; Brida, M.; Carlsen, J.; Coats, A.J.S.; Escribano-Subias, P.; Ferrari, P.; et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 2023, 61, 2200879. [Google Scholar] [CrossRef] [PubMed]
- Kramm, T.; Wilkens, H.; Fuge, J.; Schäfers, H.-J.; Guth, S.; Wiedenroth, C.B.; Weingard, B.; Huscher, D.; Pittrow, D.; Cebotari, S.; et al. Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany. Clin. Res. Cardiol. 2018, 107, 548–553. [Google Scholar] [CrossRef]
- Skride, A.; Sablinskis, K.; Lejnieks, A.; Rudzitis, A.; Lang, I. Characteristics and survival data from Latvian pulmonary hypertension registry: Comparison of prospective pulmonary hypertension registries in Europe. Pulm. Circ. 2018, 8, 2045894018780521. [Google Scholar] [CrossRef] [PubMed]
- Ende-Verhaar, Y.M.; Cannegieter, S.C.; Vonk Noordegraaf, A.; Delcroix, M.; Pruszczyk, P.; Mairuhu, A.T.A.; Huisman, M.V.; Klok, F.A. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: A contemporary view of the published literature. Eur. Respir. J. 2017, 49, 1601792. [Google Scholar] [CrossRef]
- Delcroix, M.; Lang, I.; Pepke-Zaba, J.; Jansa, P.; D’Armini, A.M.; Snijder, R.; Bresser, P.; Torbicki, A.; Mellemkjaer, S.; Lewczuk, J.; et al. Long-Term Outcome of Patients with Chronic Thromboembolic Pulmonary Hypertension. Circulation 2016, 133, 859–871. [Google Scholar] [CrossRef]
- van Thor, M.C.J.; ten Klooster, L.; Snijder, R.J.; Post, M.C.; Mager, J.J. Long-term clinical value and outcome of riociguat in chronic thromboembolic pulmonary hypertension. IJC Heart Vasculature 2019, 22, 163–168. [Google Scholar] [CrossRef] [PubMed]
- Jenkins, D.; Madani, M.; Fadel, E.; D’Armini, A.M.; Mayer, E. Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur. Respir. Rev. 2017, 26, 160111. [Google Scholar] [CrossRef] [PubMed]
- Condliffe, R.; Kiely, D.G.; Gibbs, J.S.R.; Corris, P.A.; Peacock, A.J.; Jenkins, D.P.; Hodgkins, D.; Goldsmith, K.; Hughes, R.J.; Sheares, K.; et al. Improved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension. Am. J. Respir. Crit. Care Med. 2008, 177, 1122–1127. [Google Scholar] [CrossRef]
- Skoro-Sajer, N.; Marta, G.; Gerges, C.; Hlavin, G.; Nierlich, P.; Taghavi, S.; Sadushi-Kolici, R.; Klepetko, W.; Lang, I.M. Surgical specimens, haemodynamics and long-term outcomes after pulmonary endarterectomy. Thorax 2014, 69, 116–122. [Google Scholar] [CrossRef]
- Madani, M.; Mayer, E.; Fadel, E.; Jenkins, D.P. Pulmonary Endarterectomy. Patient Selection, Technical Challenges, and Outcomes. Ann. Am. Thorac. Soc. 2016, 13 (Suppl. S3), S240–S247. [Google Scholar]
- Cannon, J.E.; Su, L.; Kiely, D.G.; Page, K.; Toshner, M.; Swietlik, E.; Treacy, C.; Ponnaberanam, A.; Condliffe, R.; Sheares, K.; et al. Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary Endarterectomy. Circulation 2016, 133, 1761–1771. [Google Scholar] [CrossRef] [PubMed]
- Jaïs, X.; D’Armini, A.M.; Jansa, P.; Torbicki, A.; Delcroix, M.; Ghofrani, H.A.; Hoeper, M.M.; Lang, I.M.; Mayer, E.; Pepke-Zaba, J.; et al. Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a Randomized, Placebo-Controlled Trial. J. Am. Coll. Cardiol. 2008, 52, 2127–2134. [Google Scholar] [CrossRef] [PubMed]
- Ghofrani, H.-A.; D’Armini, A.M.; Grimminger, F.; Hoeper, M.M.; Jansa, P.; Kim, N.H.; Mayer, E.; Simonneau, G.; Wilkins, M.R.; Fritsch, A.; et al. Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension. N. Engl. J. Med. 2013, 369, 319–329. [Google Scholar] [CrossRef] [PubMed]
- Ghofrani, H.-A.; Simonneau, G.; D’Armini, A.M.; Fedullo, P.; Howard, L.S.; Jaïs, X.; Jenkins, D.P.; Jing, Z.-C.; Madani, M.M.; Martin, N.; et al. Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): Results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study. Lancet Respir. Med. 2017, 5, 785–794. [Google Scholar] [CrossRef] [PubMed]
- Simonneau, G.; D’Armini, A.M.; Ghofrani, H.-A.; Grimminger, F.; Jansa, P.; Kim, N.H.; Mayer, E.; Pulido, T.; Wang, C.; Colorado, P.; et al. Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: Data from the CHEST-2 open-label, randomised, long-term extension trial. Lancet Respir. Med. 2016, 4, 372–380. [Google Scholar] [CrossRef] [PubMed]
- Phan, K.; Jo, H.E.; Xu, J.; Lau, E.M. Medical Therapy Versus Balloon Angioplasty for CTEPH: A Systematic Review and Meta-Analysis. Heart Lung Circ. 2018, 27, 89–98. [Google Scholar] [CrossRef] [PubMed]
- Kim, N.H.; Delcroix, M.; Jais, X.; Madani, M.M.; Matsubara, H.; Mayer, E.; Ogo, T.; Tapson, V.F.; Ghofrani, H.-A.; Jenkins, D.P. Chronic thromboembolic pulmonary hypertension. Eur. Respir. J. 2019, 53. [Google Scholar] [CrossRef] [PubMed]
- Lang, I.; Meyer, B.C.; Ogo, T.; Matsubara, H.; Kurzyna, M.; Ghofrani, H.-A.; Mayer, E.; Brenot, P. Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension. Eur. Respir. Rev. 2017, 26, 160119. [Google Scholar] [CrossRef] [PubMed]
- Kennedy, M.K.; Kennedy, S.A.; Tan, K.T.; de Perrot, M.; Bassett, P.; McInnis, M.C.; Thenganatt, J.; Donahoe, L.; Granton, J.; Mafeld, S. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis. Cardiovasc. Interv. Radiol. 2023, 46, 5–18. [Google Scholar] [CrossRef]
- Khan, M.S.; Amin, E.; Memon, M.M.; Yamani, N.; Siddiqi, T.J.; Khan, S.U.; Murad, M.H.; Mookadam, F.; Figueredo, V.M.; Doukky, R.; et al. Meta-analysis of use of balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Int. J. Cardiol. 2019, 291, 134–139. [Google Scholar] [CrossRef]
- Mizoguchi, H.; Ogawa, A.; Munemasa, M.; Mikouchi, H.; Ito, H.; Matsubara, H. Refined Balloon Pulmonary Angioplasty for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension. Circ. Cardiovasc. Interv. 2012, 5, 748–755. [Google Scholar] [CrossRef] [PubMed]
- Inami, T.; Kataoka, M.; Yanagisawa, R.; Ishiguro, H.; Shimura, N.; Fukuda, K.; Yoshino, H.; Satoh, T. Long-Term Outcomes after Percutaneous Transluminal Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. Circulation 2016, 134, 2030–2032. [Google Scholar] [CrossRef] [PubMed]
- Ravnestad, H.; Andersen, R.; Birkeland, S.; Svalebjørg, M.; Lingaas, P.S.; Gude, E.; Gullestad, L.; Kvitting, J.-P.; Broch, K.; Andreassen, A.K. Pulmonary endarterectomy and balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: Comparison of changes in hemodynamics and functional capacity. Pulm. Circ. 2023, 13, e12199. [Google Scholar] [CrossRef]
- Aggarwal, V.; Giri, J.; Visovatti, S.H.; Mahmud, E.; Matsubara, H.; Madani, M.; Rogers, F.; Gopalan, D.; Rosenfield, K.; McLaughlin, V.V.; et al. Status and Future Directions for Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease with and without Pulmonary Hypertension: A Scientific Statement from the American Heart Association. Circulation 2024. [Google Scholar] [CrossRef] [PubMed]
- Kawakami, T.; Matsubara, H.; Shinke, T.; Abe, K.; Kohsaka, S.; Hosokawa, K.; Taniguchi, Y.; Shimokawahara, H.; Yamada, Y.; Kataoka, M.; et al. Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): An open-label, randomised controlled trial. Lancet Respir. Med. 2022, 10, 949–960. [Google Scholar] [CrossRef] [PubMed]
- Ogawa, A.; Satoh, T.; Fukuda, T.; Sugimura, K.; Fukumoto, Y.; Emoto, N.; Yamada, N.; Yao, A.; Ando, M.; Ogino, H.; et al. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension. Circ. Cardiovasc. Qual. Outcomes 2017, 10, e004029. [Google Scholar] [CrossRef] [PubMed]
- Poch, D.S.; Mahmud, E.; Patel, M.; Papamatheakis, D.; Fernandes, T.; Kerr, K.; Yang, J.; Pretorius, V.; Madani, M.M.; Kim, N.H. Patient Selection for Balloon Pulmonary Angioplasty: Six year results from a high volume PTE surgical center. Pulm. Circ. 2022, 12, e12148. [Google Scholar] [CrossRef] [PubMed]
- Darocha, S.; Roik, M.; Kopeć, G.; Araszkiewicz, A.; Furdal, M.; Lewandowski, M.; Jacheć, W.; Grabka, M.; Banaszkiewicz, M.; Pietrasik, A.; et al. Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension: A Multicentre Registry. EuroIntervention 2022, 17, 1104–1111. [Google Scholar] [CrossRef] [PubMed]
- Wiedenroth, C.B.; Deissner, H.; Adameit, M.S.D.; Kriechbaum, S.D.; Ghofrani, H.-A.; Breithecker, A.; Haas, M.; Roller, F.; Rolf, A.; Hamm, C.W.; et al. Complications of Balloon Pulmonary Angioplasty for Inoperable Chronic Thromboembolic Pulmonary Hypertension: Impact on the Outcome. J. Heart Lung Transpl. 2022, 41, 1086–1094. [Google Scholar] [CrossRef]
- Kauliņš, R.; Rudzītis, A.; Lejnieks, A.; Kigitoviča, D.; Skride, A. Baseline Clinical Characteristics and Incidence of Chronic Thromboembolic Pulmonary Hypertension Patients in Latvia, 2019–2020. Medicina 2023, 59, 1426. [Google Scholar] [CrossRef]
- Sablinskis, K.; Sablinskis, M.; Lejnieks, A.; Skride, A. Growing Number of Incident Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Patients in Latvia: A Shifting Epidemiological Landscape? Data from a National Pulmonary Hypertension Registry. Eur. J. Intern. Med. 2019, 59, e16–e17. [Google Scholar] [CrossRef] [PubMed]
- Kigitovica, D.; Rusa, E.; Rudzitis, A.; Skride, A. Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Incidence in Latvia in 2021 According to the New Definition. Eur. J. Intern. Med. 2022, 106, 152–153. [Google Scholar] [CrossRef] [PubMed]
- Calé, R.; Ferreira, F.; Pereira, A.R.; Repolho, D.; Sebaiti, D.; Alegria, S.; Vitorino, S.; Santos, P.; Pereira, H.; Brenot, P.; et al. Safety and Efficacy of Balloon Pulmonary Angioplasty in a Portuguese Pulmonary Hypertension Expert Center. Rev. Port. Cardiol. (Engl. Ed.) 2021, 40, 727–737. [Google Scholar] [CrossRef] [PubMed]
- Velázquez, M.; Albarrán, A.; Hernández, I.; López-Gude, M.J.; Sarnago, F.; Martín, R.; Arribas, F.; Escribano, P. Balloon Pulmonary Angioplasty for Inoperable Patients with Chronic Thromboembolic Pulmonary Hypertension. Obs. Study A Ref. Unit. Rev. Esp. Cardiol. (Engl. Ed.) 2019, 72, 224–232. [Google Scholar] [CrossRef]
- Kataoka, M.; Inami, T.; Kawakami, T.; Fukuda, K.; Satoh, T. Balloon Pulmonary Angioplasty (Percutaneous Transluminal Pulmonary Angioplasty) for Chronic Thromboembolic Pulmonary Hypertension: A Japanese Perspective. JACC Cardiovasc. Interv. 2019, 12, 1382–1388. [Google Scholar] [CrossRef] [PubMed]
- Lang, I.M.; Andreassen, A.K.; Andersen, A.; Bouvaist, H.; Coghlan, G.; Escribano-Subias, P.; Jansa, P.; Kopec, G.; Kurzyna, M.; Matsubara, H.; et al. Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Clinical Consensus Statement of the ESC Working Group on Pulmonary Circulation and Right Ventricular Function. Eur. Heart J. 2023, 44, 2659–2671. [Google Scholar] [CrossRef]
- Olsson, K.M.; Wiedenroth, C.B.; Kamp, J.-C.; Breithecker, A.; Fuge, J.; Krombach, G.A.; Haas, M.; Hamm, C.; Kramm, T.; Guth, S.; et al. Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: The initial German experience. Eur. Respir. J. 2017, 49, 1602409. [Google Scholar] [CrossRef]
- Darocha, S.; Araszkiewicz, A.; Kurzyna, M.; Banaszkiewicz, M.; Jankiewicz, S.; Dobosiewicz, A.; Sławek-Szmyt, S.; Janus, M.; Grymuza, M.; Pietrasik, A.; et al. Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension. J. Clin. Med. 2021, 10, 1038. [Google Scholar] [CrossRef] [PubMed]
- Bashir, R.; Noory, A.; Oliveros, E.; Romero, C.M.; Maruthi, R.; Mirza, A.; Lakhter, V.; Zhao, H.; Brisco-Bacik, M.; Vaidya, A.; et al. Refined Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Hypertension. JACC Adv. 2023, 2, 100291. [Google Scholar] [CrossRef]
- Kalra, R.; Duval, S.; Thenappan, T.; Raveendran, G.; Pritzker, M.; Prisco, S.Z.; Prins, K.W. Comparison of Balloon Pulmonary Angioplasty and Pulmonary Vasodilators for Inoperable Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis. Sci. Rep. 2020, 10, 8870. [Google Scholar] [CrossRef]
- Hoole, S.P.; Coghlan, J.G.; Cannon, J.E.; Taboada, D.; Toshner, M.; Sheares, K.; Fletcher, A.J.; Martinez, G.; Ruggiero, A.; Screaton, N.; et al. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: The UK experience. Open Heart 2020, 7, e001144. [Google Scholar] [CrossRef] [PubMed]
- Inami, T.; Kataoka, M.; Shimura, N.; Ishiguro, H.; Yanagisawa, R.; Fukuda, K.; Yoshino, H.; Satoh, T. Pressure-wire-guided percutaneous transluminal pulmonary angioplasty: A breakthrough in catheter-interventional therapy for chronic thromboembolic pulmonary hypertension. JACC Cardiovasc. Interv. 2014, 7, 1297–1306. [Google Scholar] [CrossRef] [PubMed]
- Ogo, T. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension. Curr. Opin. Pulm. Med. 2015, 21, 425–431. [Google Scholar] [CrossRef] [PubMed]
- Andreassen, A.K.; Wergeland, R.; Simonsen, S.; Geiran, O.; Guevara, C.; Ueland, T. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension. Am. J. Cardiol. 2006, 98, 525–529. [Google Scholar] [CrossRef]
- Andreassen, A.K.; Ragnarsson, A.; Gude, E.; Geiran, O.; Andersen, R. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension. Heart 2013, 99, 1415–1420. [Google Scholar] [CrossRef]
Concomitant Diseases | Number of Patients, (%) |
---|---|
Systemic arterial hypertension | 7 (77%) |
Dyslipidemia | 7 (77%) |
Diabetes | 3 (33%) |
Coronary artery disease | 4 (44%) |
COPD | 0 |
Chronic kidney disease | 1 (11%) |
Atrial fibrillation | 1 (11%) |
CTEPH risk factors | |
History of acute pulmonary embolism | 9 (100%) |
History of deep vein thrombosis | 2 (22%) |
Recurrence of pulmonary embolism | 1 (11%) |
Chronic inflammatory disease | 0 |
Atrial septal defect | 0 |
VA shunt | 0 |
History of splenectomy | 0 |
Antiphospholipid syndrome | 0 |
History of malignancy | 0 |
Total no. patients | 9 | |
Age (years) | 68.8 ± 11.8 | |
Female sex (%) | 67 | |
Total no. procedures | 12 | |
Median no. procedures per person | 1 | |
Baseline | After BPA | |
6MWD (m) | 300.00 ± 133.47 | 420.00 ± 147.23 |
FC (WHO) I/II/III/IV | 0/3/6/0 | 1/2/6/0 |
BNP (pg/mL) | 289 (704) | 186 (407) |
SpO2 (%) | 93.11 ± 5.41 | 94 ± 4.21 |
30-day mortality (%) | - | 0 |
Hemodynamic characteristics | ||
mPAP (mmHg) | 43.00 ± 15.56 | |
CO (L/min) | 5.08 ± 0.37 | |
CI (L/min/m2) | 2.30 ± 1.48 | |
PVR (WU) | 7.85 ± 2.89 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Krigere, A.; Kalejs, V.R.; Kaulins, R.; Rudzitis, A.; Bondare, L.; Sablinskis, M.; Lejnieks, A.; Kigitovica, D.; Kurzyna, M.; Skride, A. The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia. Medicina 2024, 60, 568. https://doi.org/10.3390/medicina60040568
Krigere A, Kalejs VR, Kaulins R, Rudzitis A, Bondare L, Sablinskis M, Lejnieks A, Kigitovica D, Kurzyna M, Skride A. The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia. Medicina. 2024; 60(4):568. https://doi.org/10.3390/medicina60040568
Chicago/Turabian StyleKrigere, Anna, Verners Roberts Kalejs, Ricards Kaulins, Ainars Rudzitis, Liga Bondare, Matiss Sablinskis, Aivars Lejnieks, Dana Kigitovica, Marcin Kurzyna, and Andris Skride. 2024. "The Initial Experience of Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Latvia" Medicina 60, no. 4: 568. https://doi.org/10.3390/medicina60040568